Introduction
All receptors that interact with effector systems to modulate the intracellular levels of a second messenger appear to do so via the intermediacy of members of a family of guanine nucleotide binding proteins (Gproteins). Rodbell and coworkers, whilst studying the ability of the peptide hormone glucagon to stimulate adenylate cyclase activity in hepatocytes, were the first to demonstrate definitively a specific requirement for guanine nucleotides in hormonal function (Rodbell et al., 1971a) . Since these pioneering studies, it has become increasingly clear that a considerable number of unique but highly homologous G-proteins are the sites of action for guanine nucleotides in these processes. The purpose of this review will be to discuss the techniques that are currently in widespread use to identify and assess the functions of individual members of a subfamily of these signal-transducing G-proteins which are substrates for ADP-ribosylation catalysed by pertussis toxin.
Guanine nucleotide binding proteins: structure and function All of the well-characterized G-proteins appear to be heterotrimeric in structure, comprising the following subunits.
(1) A unique a subunit which binds guanine nucleotides and which possesses an intrinsic GTPase activity. In many, but not all, cases the a subunits of individual Gproteins may be substrates for ADP-ribosylation catalysed by certain bacterial toxins. These a subunits range Areas of identity are shaded. In cases in which identity at particular residues does not extend across all the polypeptides, then the closest homology to the 'G1-like' subfamily is indicated. Where each of G11, G12 and G.3 is represented by a different amino acid at one position then no further homology to G., TI or T2 is noted. The sequences for G., G,l, G,2 and G,3 are taken from Jones & Reed (1987) , that for TI from Tanabe et al. (1985) and that for T2 from Lochrie et al. (1985) . in apparent molecular mass, under denaturing gel electrophoresis, between 39 and 52 kDa. However, at the level of primary amino acid sequence they are very highly conserved ( Fig. 1 ). As will be discussed below, it is this conservation of sequence and of overall tertiary structure which is the cause of most of the difficulties in attempts to identify these G-proteins unambiguously. It is, however, the individuality of the different a subunits which both define the separate G-proteins and which can most appropriately and usefully be analysed.
(2) A , subunit of some 35-36 kDa on denaturing gels. Until recently it had been generally accepted that a common pool of a single / subunit was shared between different a subunits which were expressed within a single cell type or tissue (Manning & Gilman, 1983) . It had been noted, however, that purification of G-proteins from a number of sources led to the resolution of two /, subunits (Sternweis et al., 1981; Sternweis & Robishaw, 1984) that were immunologically distinct (Roof et al., 1985; Evans et al., 1987) and the recent identification of clones for two individual forms of the ,3 subunit has confirmed the presence of at least two genes encoding , subunits Fong et al., 1987; Gao et al., 1987) . No information is currently available as to whether each subtype of the ,# subunit is able to interact exclusively with a particular subset of a subunits.
(3) A y subunit. Relatively little attention has been paid to the nature and potential diversity of the y (Hildebrandt et al., 1985; Gierschik et al., 1985; Evans et al., 1987) . In each case these are small polypeptides of some 8 kDa. In all physiological situations the relevant y subunit remains tightly associated with the / subunit. The diversities in structure noted at the levels of the / and y subunits at least raise the possibility of the existence of numerous different holomeric isotypes of the individual G-proteins. However, no evidence to suggest that this can indeed occur has been presented.
The function of the G-proteins is to couple agonistactivated receptors to the effector systems that alter intracellular concentrations of second messengers. As this process must be of limited duration, then the Gprotein is required to undergo a cyclical pattern of activation followed by a subsequent deactivation (Fig.  2) . In the resting state the G-protein exists in the holomeric form with GDP bound to the nucleotide binding site of the a subunit. Upon receptor activation of the G-protein, then the rate of release of GDP, which appears to be the rate limiting step in G-protein activation/deactivation, is enhanced and the released GDP is replaced by GTP (see Gilman, 1987, for review). With GTP in the nucleotide binding site and in the presence of Mg2" then the holomeric G-protein can dissociate into an active a subunit with GTP bound and free /3/y subunits. This active a subunit is then able to interact with the catalytic moiety of a particular secondmessenger-generation system to alter the rate of synthesis of the second messenger. Hydrolysis of the terminal phosphate of the bound GTP by the intrinsic GTPase activity deactivates the a subunit and in this GDP-bound form it is then able to reassociate with //y subunits to restore the G-protein to the deactivated state.
Identification of G-protein-linked receptors
Alterations in receptor-agonist binding interactions in the presence of analogues of GTP. Early experiments on the binding of ligands to receptors that produce stimulation of adenylate cyclase noted that GTP interferred with the binding of glucagon to its receptors (Rodbell et al., 1971b) . It was subsequently noted that guanine nucleotide effects on /3-adrenergic receptor binding were limited to agonists and not antagonists (Maguire etal., 1976 now close to ideal. These data were consistent with a model whereby agonists interacted with receptors which were in intimate association with a GDP-liganded, and hence unstimulated, G-protein with higher affinity than they did with receptors which were not in such contact with the G-protein. Similar experiments prompted the conclusion that receptors that mediated inhibition of adenylate cyclase must also interact with a G-protein (see Rodbell, 1980) and arguments of this nature were then later extended to provide evidence for the interaction of the Ca2" mobilizing receptors with G-proteins. Historically, therefore, guanine nucleotide sensitivity of agonistbinding affinity has often provided the initial suggestion that a particular receptor interacts with a G-protein.
The limitation of this type of approach is that it can offer no information as to the molecular nature of the Gprotein involved. Binding studies performed on membranes derived from tissues pretreated with a toxin isolated from supernatant cultures of Bordetella pertussis have been used to subdivide further the nature of receptor-linked G-proteins (Kurose et al., 1983; Hsia et al, 1984) . In these experiments agonist affinity for the displacement of [3H]antagonist binding was reduced in membranes of pertussis toxin-treated cells in comparison to that in membranes from untreated cells. Furthermore, addition of poorly hydrolysed analogues of GTP was not able to reduce agonist affinity for the receptor further, indicating that pertussis toxin pretreatment had modified the relevant G-protein in such a manner that it now appeared to be functionally uncoupled from the receptor. As discussed below, however, these studies are of restricted usefulness due to the limited specificity of this toxin. They were, however, of use in demonstrating that receptors that mediate inhibition of adenylase cyclase do so by interacting with a pertussis toxin-sensitive Gprotein(s) and also that Ca2" mobilizing receptors in a number of (Nakamura & Ui, 1985; Ohta et al., 1985) , but not all, tissues (Helper & Harden, 1986; Martin et al., 1986) , also interact with a pertussis toxin-sensitive Gprotein. Unfortunately, the prospectively erroneous, if most simple, conclusion, i.e. that the G-protein involved in inhibition of adenylate cyclase and stimulation of inositol phospholipid turnover was one and the same, was derived from this approach.
GTPase studies. The interaction of agonist with receptor promotes the release of GDP from a relevant Gprotein and hence allows the binding of GTP. This is followed by the subsequent hydrolysis of the nucleotid( by the GTPase activity of the G-protein. Measurement of this enhanced rate of GTPase activity of a membrane in response to agonist thus provides a simple, convenient and direct assessment of the interaction of a receptor with a G-protein(s). This approach was first employed by Cassel & Selinger (1976 the hydrolysis of GTP by all of the G-proteins within that membrane as well as by other enzymic reactions. Gprotein-related GTP hydrolysis is such that the Km of these enzymes for GTP is low. Thus it is useful to subtract from the total GTPase activity a blank in which hydrolysis in the presence of a high concentration of GTP (50-100 ftM) is assessed. Also, the contribution of any particular G-protein to the basal low-Km GTPase activity will be dependent upon: (1) the relative proportions of the various G-proteins present in the membrane, and (2) their relative rates of GTP hydrolysis. Thus, the observations that receptor-Gs interactions cannot be measured using this type of assay in a number of systems and have only been reproducibly noted in a few systems, for example in avian erythrocytes (Cassel & Selinger, 1976) and in platelets (Houslay et al., 1986 ) are a reflection both that levels of Gs tend to be lower than those of many other G-proteins and that the rate of GTP hydrolysis by purified G. is extremely low. As such, receptor-mediated stimulation of this rate may still allow the situation in which the signal of increased hydrolysis of GTP by activated G. remains lost within the 'noise' due to the basal rates of hydrolysis by the other Gproteins present.
In general, much greater success has been achieved using GTPase studies for receptors linked to pertussis toxin-sensitive G-proteins (Koski & Klee, 1981; Aktories & Jakobs, 1981) . This is presumably due to the higher abundance of these proteins and their greater enzymic capacity. As with binding studies, however, it has not generally been possible to further subdivide receptor interactions with particular pertussis toxin-sensitive Gproteins due to the lack of specificity of this toxin. Assessments of the specificity of receptor-G-protein interactions within the native membrane have however been addressed by performing GTPase activity experiments (see Table 1 ). The rationale for these is that activation of the entire population of receptors in a membrane preparation with a saturating concentration of a full agonist will prospectively lead to the activation of the full complement G-protein(s) with which that receptor is able to interact. Thus, addivity of receptorstimulated GTPase activity following addition of two agonists which interact with independent receptors would indicate the activation of separate pools of Gprotein, and by extension, different G-proteins. This approach has been elegantly employed by, for example, Houslay et al. (1986a,b) to examine a range of receptor-G-protein interactions in human platelets. A further example of the usefulness of this technique has been the demonstration (McKenzie et al., 1988a ) that in membranes ofneuroblastoma x glioma hybrid cells, individual receptors for opioid peptides and for a growth factor interact with separate, distinct pertussis toxin-sensitive G-proteins. Of course, if agonist interaction with a particular receptor is able to activate only a small proportion of the population of a particular G-protein, then GTPase additivity would be observed to a second receptor able to activate the same G-protein. This is likely to be the case in some tissues, e.g. brain, where the pertussis toxin-sensitive G-proteins may represent some 1-2 0% of the total membrane protein (Sternweis & Robishaw, 1984; Neer et al., 1984; .
Bacterial toxins. Exotoxins isolated from supernatant cultures of Vibrio cholerae and of Bordetella pertussis have proved to be invaluable tools in the characterization of, in particular, the G-proteins associated with the adenylate cyclase signalling system. Bordetella pertussis, the causative agent of whooping cough, produces a number of toxins. One of these, named islet activating protein or simply pertussis toxin, was originally shown by Ui and collaborators to produce sustained alterations in receptor-mediated control of cyclic AMP production (Katada & Ui, 1979 . Pertussis toxin consists of six subunits, five of which are dissimilar. Of these, the SI subunit (28 kDa) is as effective as the holomeric toxin when it is added to membrane preparations, but is totally inactive on whole cells. The other subunits, by contrast, are important in the attachment of the toxin to cells and the entry of toxin into the cell (see Foster & Kinney, 1984, for review) . Activation of the toxin in vitro is achieved by treatment with a reducing agent such as dithiothreitol. The S1 subunit is an ADP-ribosyltransferase and catalyses the transfer of the ADP-ribose moiety of NADI to the a. subunit of relevant G-protein substrates. Some of the initial experiments with this toxin demonstrated an enhancement of GTP activation of adenylate cyclase in rat glioma C6 cells. This was concomitant with the transfer of ADP-ribose from NAD+ to a 41 kDa membrane-associated polypeptide (Katada & Ui, 1982) . The release of tonic inhibition of adenylate cyclase activity paralleled by the modification of the 41 kDa protein thus identified this polypeptide as the putatively proposed (Rodbell, 1980) Figure thus demonstrates the potential difficulty in the unambiguous identification of the molecular identity of a pertussis toxin-sensitive G-protein when assessment is based on pertussis toxin-catalysed ADP-ribosylation alone.
G.) from brain (Sternweis & Robishaw, 1984; Neer et al., 1984; and then by the recognition that further pertussis toxin-sensitive Gproteins were expressed which were immunologically distinct from brain G, and G. Gierschik et al., 1986c) . Initial demonstrations that more than a single pertussis toxin-sensitive G-protein could be expressed came from attempts to purify 'G,' from bovine brain. Three groups of workers noted that purified preparations of pertussis toxin substrates from brain contained either two (Sternweis & Robishaw, 1984; or three (Neer et al., 1984) polypeptides in the 39-41 kDa range. These appeared to be at least immunologically if not functionally distinct (see later sections on immunological characterization and on reconstitution studies). Earlier studies on the purification of the pertussis toxin-sensitive G-protein had used tissues such as rabbit liver and had identified but a single pertussis toxin substrate (see, for example, Bokoch et al., 1984) . either rods or cones (Lochrie et al., 1985; Yatsunami et al., 1985) , three genes coding for 'Gi-like' proteins, named for the chronology of their identification Gil, Gi2 and G13 (Reed & Jones, 1987; Suki et al., 1987; Beals et al., 1987) , and G. (Itoh et al., 1986; Jones & Reed, 1987) ( Fig. 1) . In addition, two separate mRNAs which hybridize to a Go specific probe have been identified (Jones & Reed, 1987) . It is thus possible that yet further forms may be demonstrated. There is thus no justification, in the absence of rigorous biochemical experimentation, to assigning a pertussis toxin-sensitive response to any particular member of this family of proteins. Herein lies the crux of the problem. Despite this, pertussis toxin remains a valuable tool in studies of hormone and neurotransmitter function, provided that the results obtained with the toxin are not overinterpreted.
In contrast to pertussis toxin, cholera toxin has a molecular mass of 84415 and is composed of two protomers, A and B, which interact with one another in a non-covalent manner. The A protomer represents the enzymic moiety of the toxin whilst the B protomer, which consists of five identical polypeptide chains, interacts with a cell surface receptor, ganglioside GM, and hence in some manner promotes the entry of the A protomer into the cell (see Foster & Kinney, 1984) . Like pertussis toxin, the activated A protomer is an ADPribosyltransferase which in the presence of a second protein called ADP-ribosylation factor (ARF) (Kahn & Gilman, 1984 ) is able to catalyse the transfer of ADPribose from NAD+ to an arginine residue in the a subunit of Gs. This covalent modification stabilizes the GTPbound form of the a subunit of Gs and as the GTPase activity of the a subunit is inhibited then G. is maintained in a permanently activated state (Cassel & Selinger, 1977) . Adenylate cyclase is thus maximally activated and is no longer sensitive to hormonal activation. It is necessary to preactivate the toxin in vitro by prior treatment with a reducing agent such as dithiothreitol to separate the A and B protomers before the toxin will function enzymically.
The use of [32P]NAD' as substrate allows the visualization of polypeptides which are substrates for either cholera or pertussis toxin following gel electrophoresis under denaturing conditions and subsequent autoradiography. In the presence of guanine nucleotides, cholera toxin is able to promote the specific incorporation of radioactivity only into the a subunit(s) of Gs. The apparent molecular mass of this polypeptide(s) is normally estimated to be either 45 or 52 kDa and these two forms appear to represent differentially spliced products derived from a single gene (Bray et al., 1986; Robishaw et al., 1986) .
Depending upon the tissue studied, pertussis toxin is able to catalyse ADP-ribosylation of at least three polypeptides. Whilst these all migrate in denaturing gel electrophoresis with apparent molecular masses between 39 and 41 kDa, they can be resolved sufficiently to be noted as unique (Neer et al., 1984; Toutant et al., 1987) .
In the case of cholera toxin it has been noted that, when the ADP-ribosylation reaction is performed in the absence of guanine nucleotides, then besides incorporation of radioactivity into the Gs xa polypeptide(s), labelling of a polypeptide of some 40 kDa can be observed (Fig. 4) . Whilst this observation has been noted for at least a macrophage-like cell line (Aksamit et al., 1985) , polymorphonuclear leukocytes (Verghese et al., 1986) , a rat glioma cell line (Milligan, 1987) , adipocytes (Owens et al., 1985) , and a neuroblastoma x glioma hybrid cell line (Milligan & McKenzie 1988) , this does not appear to be a universal phenomenon (my published work). This polypeptide appears also to be a substrate for pertussis toxin, as prior treatment in vivo of either the rat glioma cell line or the neuroblastoma x glioma cell line with pertussis toxin prevents subsequent cholera toxin-catalysed ADP-ribosylation of 40 kDa polypeptide. Further, it has been noted that cholera toxin-catalysed ADPribosylation of a 40 kDa polypeptide in adipocytes has functional consequences equivalent to treatment with pertussis toxin (Owens et al., 1985) .
The site of pertussis toxin-catalysed ADP-ribosylation in G-proteins that are substrates for this toxin is a conserved cysteine residue located four amino acids from the C-terminus. In contrast, however, the site of action of cholera toxin in Gs is an arginine residue, which in the postulated tertiary structures of the G-protein (Masters et al., 1986) , is located close to the guanine nucleotide binding domain. Interestingly, the primary structure in the region around this arginine is highly conserved in all the G-proteins which have so far been identified and this arginine is invariant in the equivalent position of the other G-proteins. It must then be asked why all Gproteins are not substrates for cholera toxin under all conditions? This may reflect the close proximity of the guanine nucleotide binding domain to the relevant arginine residue and suggests that occupancy of this site by a guanine nucleotide might hinder access of cholera toxin. Evidence in favour of this proposal is provided by the observations that the pertussis toxin substrates only become substrates for cholera toxin in the absence of added guanine nucleotides. Also, addition of agonists for receptors that interact with the pertussis toxin-sensitive G-protein produces an enhancement of cholera toxin catalysis of ADP-ribosylation of this G-protein (Gierschik & Jakobs, 1987; Milligan, 1988; Milligan & McKenzie, 1988 ) (see Fig. 5 ). (a) or absence (b) of exogenously added GTP (100 gM) as described by Milligan (1987) . No incorporation of radioactivity into any of the three polypeptides was noted in the absence of cholera toxin. The 40 kDa band labelled, only in the absence of GTP, in this system, represents the a subunit of Gi2 (Milligan, 1988 Two particular difficulties exist in the use, in vitro, of bacterial toxin-catalysed ADP-ribosylation as a means of identification and quantification of pertussis toxinsensitive G-proteins. The first is that, depending upon the tissue under investigation, less than the theoretical maximal degree of ADP-ribosylation may occur (i.e. 1 mol of ADP-ribose/mol of pertussis toxin-sensitive Gprotein). A particular problem which has been noted, but which is only infrequently assessed, is that the [32P]NAD+ can be degraded by NAD-glycohydrolases present and hence is not available as a substrate for the toxin. Rat brain contains high levels of both 'G1' (now identified as GM 1) and Go. As assessed by Western blotting techniques, levels of both of these G-proteins increase in neonatal tissue to reach adult levels by 20-30 days (Milligan et al., 1987a) . However, results obtained from pertussis toxin-catalysed ADP-ribosylation indicated that levels of these proteins fell sharply with age (Milligan et al., 1987d) . Examination of this paradox demonstrated the appearance of an NAD-glycohydrolase with age, such that in older, but not younger, animals, essentially the entire pool of [32P]NAD' was destroyed in a short time span (Milligan et al., 1987d) .
Secondly, the nature of the guanine nucleotide bound to a G-protein can substantially alter the rate of both pertussis and cholera toxin-catalysed ADP-ribosylations. It was noted above that cholera toxin-catalysed ADPribosylation of G-proteins that are traditionally considered to be substrates for pertussis toxin does not appear to occur to any great extent if a guanine nucleotide is bound to the G-protein. However, the nature of the guanine nucleotide bound also affects the rate of pertussis toxin-catalysed ADP-ribosylation. In the presence of the GDP analogue GDP/?S, the rate of pertussis toxincatalysed ADP-ribosylation of a 40 kDa polypeptide in rat glioma C6 cell membranes was some four times greater than when the same experiment was performed in the presence of the GTP analogue GTPyS (Milligan, 1987) . Experiments such as these are traditionally interpreted to imply that pertussis toxin is better able to interact with the holomeric, unactivated forms of its substrates, which have GDP bound, than with the free, activated a subunits. Such an interpretation is well supported by observations that the separated a subunit of the pertussis toxin-sensitive G-protein G. is a very weak substrate for ADP-ribosylation but that upon addition of /3/y subunits the a subunit becomes a much improved substrate (Neer et al., 1984) . Whilst the above is certainly true, recent observations that pertussis toxin itself has a nucleotide requirement for function hinder interpretation.
A third potential problem with the use of bacterial toxins to identify G-proteins appears at this stage to be largely confined to the use of cholera toxin. A number of recent reports have suggested that prior treatment with cholera toxin can reduce subsequent receptor-mediated hydrolysis of inositol phospholipids (Imboden et al., 1986; Lo & Hughes, 1987) . However, at least in the case of vasopressin-stimulation of inositol phosphate generation in rat glomerulosa cells, where pretreatment with cholera toxin reduced the agonist response by some 60 %, this does not appear to be due to the toxin modifying a G-protein. Rather, the toxin appeared to either block access of vasopressin to the receptor or to downregulate the vasopressin receptor (Guillon et al., 1988) (Strnad & Carchman, 1987) . Identification of individual pertussis toxin-sensitive Gproteins Resolution of the different pertussis toxin-sensitive Gproteins in one-dimensional SDS/polyacrylamide gels is often poor. Whilst this can be improved by prior alkylation of the samples with N-ethylmaleimide (Sternweis & Robishaw, 1984 ) and a rank order of mobility through such gels noted such that the mobility of G. > Gi2 > G1l, greater resolution is generally required. With this in mind, a number of laboratories have adopted the use of two-dimensional electrophoresis. With this approach, resolution of a number of pertussis toxinsensitive G-proteins has been achieved. Initial experiments in this area involved the prior ADP-ribosylation of membrane preparations with pertussis toxin and [32P]NAD' to function as the detection system. However, by so doing, the electrophoretic mobility of the proteins would be altered such that the polypeptides would be more acidic than the native forms (see for example Deery et al., 1987) . More recent attempts have probed nitrocellulose blots of the resolved proteins with specific antibodies so that true isoelectric points can be estimated.
In these experiments G,i migrates with a more basic isoelectric point (6.1) than Gi2 (5.65) and the major form of G. (5.6). In brain a second form of G. can be observed with an isoelectric point near 6.0 (Backlund et al., 1988) . In support of these observations, in purification protocols, Gil and a form of Go elute in close proximity from anion exchange resins and can be relatively easily resolved from G12 and the major form of Go, which elute in later fractions (Katada et A limitation on the use of two-dimensional electrophoresis for the analysis of pertussis toxin-sensitive Gproteins is that in general the a subunits appear only poorly to penetrate the isoelectric focusing phase of the gel (Heydorn et al., 1986) . This leads to a lowering of sensitivity of the system and to marked streaking of the gel if it is overloaded. The resistance to penetration of the first dimension appears to be a property of the Nterminal region of these proteins and may relate to the covalent attachment of myristic acid Buss et al., 1987) to the glycine residue which is present as the N-terminal residue of all the pertussis toxin-sensitive G-proteins which have been characterized. Despite possessing an equivalent N-terminal sequence to the other pertussis toxin-sensitive G-proteins, the individual forms of transducin appear to lack attached myristic acid (Buss et al., 1987 Vol. 255 minimize this difficulty. The remaining 37 kDa polypeptide, which is stable to further tryptic digestion when a GTP, but not GDP, analogue is bound (Katada & Ui, 1982; Eide et al., 1987; McKenzie et al., 1988b) , is then able to enter the gel with greater freedom. Such guanine nucleotide control of the tryptic sensitivity of G-proteins had originally been noted for G8 (Hudson et al., 1981) .
Currently, the most convenient approach to the identification of individual species of pertussis toxinsensitive G-proteins involves the use of specific antisera (Fig. 6) . With the purification of 'G1' from a number of tissues, considerable efforts have been made to generate polyclonal antisera selective for individual pertussis toxin-sensitive G-proteins. These attempts have not been universally successful. Often, the use of a mixture of holomeric pertussis toxin-sensitive G-proteins isolated from brain as antigen has led to the generation of antisera containing antibodies directed against the a subunit of Go and against the ,3 subunit but within these antisera no antibodies were generated which selectively recognize forms of the a subunit of G1 (Gierschik et al., 1986a; Huff et al., 1985; Roof et al., 1985) . Why Go appears to be immunodominant in comparison to G. is not obvious given the marked homology between these proteins at the primary sequence level. At least within our own attempts to produce antisera by this route we have only succeeded in generating anti-GO antisera (Gierschik et al., 1986a) and at least anecdotal evidence, and the lack of reports to contradict this, suggest that this has generally been the experience of other workers. Recently however, Katada et al. (1987) appear to have generated a polyclonal anti-G. antiserum using purified brain G-protein as antigen. In a number of cases antiGo antisera generated in this direct fashion show some degree of cross-reactivity with other pertussis toxinsensitive G-proteins (see Huff et al., 1985, for example) and this may alter from different bleeds of the same antiserum. In many respects, given the very high levels of homology between members of this sub-family of Gproteins, it should not be surprising if a degree of crossreactivity were noted with polyclonal antisera. However, based on the recognition that domains which must interact selectively with particular classes of receptors and with different second messenger-effector systems must be exposed at the surface of the protein and hence potentially available as antigenic epitopes, then as these are likely to represent the most divergent sections of the G-protein it may be appreciated how fairly selective antisera might be generated. Anti-GO antisera of this class were first used to demonstrate that Go and G. were distinct entities (Gierschik et al., 1986a) and that Go did not simply represent a proteolytic fragment of G. (Huff et al., 1985; . However, in the absence of an antiserum generated against purified Gi, it was the cross-reactivity with brain Gi of a polyclonal antiserum raised against holomeric bovine rod transducin (Pines et al., 1985) that first permitted the mapping of tissue and regional location of brain G, (now called G 1).
These antisera were also applied to studies of the developmental regulation of Gi and of Go and were used to demonstrate that observed alterations in the levels of the pertussis toxin-labelling of membranes of NIH 3T3-LI pre-adipocytes during differentiation could mask the independent regulation of amounts of two separate pertussis toxin substrates (Gierschik et al., 1986b) .
Rather different results on the relative expression of G, and Go in this same experimental system have been detailed more recently by Watkins et al. (1987) . These same antisera have been used to assess the relative concentrations of G, and Go in a number of tissues (Milligan et al., 1987a,c; Luetje et al., 1987) . Anti-Gprotein antisera have also been productively utilized in immunocytochemical assays to determine the distributions of specific G-proteins (Worley et al., 1986; Lad et al., 1987; Terishima et al., 1987) .
The inability of these polyclonal anti-GO and anti-Gil selective antisera to stain a 40 kDa pertussis toxin substrate that was present in high levels in both human neutrophils (Gierschik et al., 1986c) and in rat glioma C6 cells further demonstrated that pertussis toxin-sensitive G-proteins other than these two were expressed in various tissues. Whilst the nature of the major pertussis toxin substrate(s) in these cells was not apparent at that stage, this has subsequently been identified as Gi2 by the use of selective antipeptide antisera (see below). However, as recently noted by Jones and Reed (1987) , based on their identification of four separate pertussis toxin-sensitive G-proteins from a rat olfactory neuroepithelial cDNA library, "the specificity of polyclonal or monoclonal antisera should be well characterized for definitive immunoanalysis ".
Based on considerations of this nature a number of laboratories have produced anti-peptide antisera directed against short synthetic peptides which, from either conventional protein sequencing or analysis of cDNA clones, can be predicted to be present in particular pertussis toxin-sensitive G-proteins. A particularly elegant example of the potential of this approach has been provided by the generation of anti-peptide antisera directed against sequences unique to two individual forms of transducin which, as deduced from separate cDNA clones, were some 78 % identical at the amino acid level (Lerea et al., 1986) . One of these antisera specifically stained rods and the other cones, demonstrating that the two G-proteins represented cell-type specific forms of transducin. Mumby et al. (1986) were the first to generate a series of antipeptide antisera against synthetic peptides corresponding to sequences of individual G-protein a subunits and were able to demonstrate that these antisera displayed greater specificity for particular G-proteins on Western blots that did antisera generated against purified G-protein a subunits.
However, no antipeptide antisera against Gi were produced in these studies. Because it had previously been noted that a polyclonal anti-transducin antiserum, CW6, which could be demonstrated to recognize an epitope close to the C-terminus of the a subunit of this protein, was able to cross-react with brain G, (Pines et al., 1985; , then Spiegel, Unson and Milligan (see for example Falloon et al., 1986; Milligan et al., 1987b; Goldsmith et al., 1987) produced antipeptide antisera directed against the C-terminal decapeptide of transducin with the hope that these antisera would also cross-react with Gi. This peptide sequence could be predicted from cDNA clones of transducin whilst the equivalent sequence of Gi was not available at that time. These antisera did in fact recognize brain G, as well as transducin on western blots, indicating that the C-terminal sequence of Gi must be similar to that of transducin. In retrospect this was not an unexpected result, as cDNA studies later demonstrated that brain G1 contained but a single conservative substitution within this region when compared to transducin. Somewhat more surprisingly, these antisera detected high levels of a 40 kDa pertussis toxin substrate in human neutrophils (Falloon et al., 1986; Goldsmith et al., 1987) and in glioma C6 cells , whereas it had previously been noted that antisera against G. or the predominant G,-like protein of brain (Gi1) were unable to recognize these forms. Further cDNA cloning studies of libraries constructed from glioma C6 cells (Itoh et al., 1986 ) and leukocytic tissues (Didsbury et al., 1987) demonstrated the potential expression of a second G,-like protein (Gi2) which had an identical C-terminal decapeptide to that of Gil and which was some 880% similar overall at the primary sequence level. An antipeptide antiserum directed against a 10-amino-acid sequence corresponding to amino acids 160-169 of this protein equally recognized the 40 kDa pertussis toxin-sensitive polypeptide of neutrophils and glioma C6 cells, confirming the identity of this protein as Gi2 . This antiserum, which did not recognize Gil, also identified low levels of Gi2 in brain tissue (Backlund et al., 1988) , which migrated between Gil and Go on denaturing gel electrophoresis. These results were consistent with the idea that the three pertussis toxin-sensitive polypeptides first identified in brain by Neer et al. (1984) represented Gil, Gi2 and Go. As noted above, the recent cloning of a third 'Gi-like' protein from both rat (Jones & Reed, 1987) and human tissues (Suki et al., 1987) further clouds attempts to demonstrate unequivocally the absolute molecular identity of pertussis toxin-sensitive Gproteins.
The most recent addition to this family of proteins (G,3) is extremely similar to Gil and in rat tissues differs in only some 22 of 354 amino acids (6 %). These modifications are scattered throughout the amino acid sequence and as such it is difficult to identify potential areas of amino acid sequence which might allow selective antipeptide antisera to be produced. The C-terminal of rat Gi3 does in fact differ in two positions from that of Gil and GT2, but both (Asp and Phe in Gil and G12 to Glu and Tyr in G,3) are but minor alterations.
Preliminary and somewhat circumstantial evidence, which relies upon the detection of mRNAs coding for both G,2 and G,3 but not Gi1 in the human cell line HL60, has been presented in conjunction with Western blot analyses, which could be interpreted to imply that antisera against the C-terminal region of tranducin do recognize Gi3 as well as the other 'Gi-like' G-proteins (Murphy et al., 1987) .
As transducin is limited in distribution to photoreceptor-containing tissues, then C-terminal antisera have been used to detect the presence and levels of 'G,-like' proteins in a range of tissues which do not express transducin (Gawler et al., 1987; Milligan et al., 1987b) . Of particular note, they have been used to demonstrate that the lack of functional Gi activity in hepatocyte membranes derived from alloxan-or streptozotocindiabetic rats corrected with reduction of the amounts of the ac subunit of a form of G1 to some 10 % of that of untreated rats (Gawler et al., 1987) . They have also been used to show that chemical treatment of rats to produce a hypothyroid state leads to a 2-fold elevation of levels of G. in membranes of adipocytes of these animals which correlated with reduced functioning of agonists which stimulate adenylate cyclase in these cells (Milligan, 1987b) . These antibodies have been particularly useful as they do not cross-react with G., in which the C-terminal region differs in five of the ten amino acids of the antigen (Fig. 7) . These antisera can also be used to detect ADPribosylated forms of 'Gi-like' proteins and of transducin although the cysteine residue, which is the ADP-ribose acceptor site, is within the antigenic epitope. The covalently modified a subunits are detected as more slowly migrating forms than the unmodified polypeptides in one-dimensional denaturing gel electrophoresis . Reconstitution studies A fundamental aim ofmany biochemical investigations is to purify parts of a multicomponent system and to then attempt to reconstitute the function of that system to assess the specific roles of the different polypeptides. Signal transduction systems are admirably suited to this task, as in the native membrane separate receptor, Gprotein and effector entities can be identified.
The isolation of a variant form of the S49 lymphoma cell line which did not generate cyclic AMP in response to ,-adrenergic agonists, despite the expression of f,-adrenergic binding sites (Insel et al., 1976) , played a major part in the definition of the role of Gs. Named cyc- (Bourne et al., 1975) , analysis of this mutant demonstrated that a normal adenylate cyclase was present in membranes of this cell but that it lacked a substrate for cholera toxin (Johson et al., 1978) . More recently, further experimentation has shown it to lack both the structural polypeptide of Gsa, as assessed in immunoblotting studies, and relevant mRNA (Harris et al., 1985) . This cell line thus facilitated the purification of G. by functioning as a highly sensitive acceptor system in reconstitution studies.
Similar mutants of pertussis toxin-sensitive G-proteins are not available. However, membranes of cells which have been pretreated with pertussis toxin can in many regards be considered to be functionally lacking these proteins. Reconstitution of membranes of these pertussis toxin-substrate-cells with various purified G-proteins (Katada et al., 1984a; thus should allow an assessment of the ability of receptors to interact with the exogenously provided G-proteins. A G-protein which can interact with a particular receptor should then be both able and sufficient: (1) to restore high-affinity agonist binding to the receptor, (2) to produce agonist-stimulated highaffinity GTPase activity and (3) to restore receptormediated alterations in second messenger generation. In short, a relevant G-protein should reverse the attenuation of receptor functioning which was produced by pertussis toxin. A considerable number of studies of this nature have been performed, usually with the aim of attempting to assess whether 'G.' and Go mediate the effects of different receptors. The overall pattern to emerge from the majority of these studies is that little selectivity is shown by receptors for the different pertussis toxinsensitive G-proteins (see Asano et al., 1985; Kikuchi et al., 1986, as examples). However, with hindsight, it is easy to argue that the validity of these studies needs to be closely re-examined because the number of pertussis toxin-sensitive G-proteins which have recently been identified, and their similarity, indicate that these reconstitution experiments may not have been performed with homogeneous populations of individual G-proteins.
Equally, the role of presumably similar or identical fl/y subunits, associated with the individual a subunits, in these experiments are difficult to assess. Inhibition of adenylate cyclase activity in reconstitution systems containing resolved adenylate cyclase catalytic subunit and a or fl/y subunits of either Gi or transducin have however indicated that the major inhibitory role is played by the ,//y subunits, presumably by combining with, and inactivating, the a subunit of G. (Cerione et al., 1986) .
The exact roles of the different subunits, however, still remains a contentious issue. In the S49 cyc-model (Katada et al., 1984b) , somatostatin is able to produce a receptor-mediated inhibition of adenylate cyclase activity (Jakobs et al., 1983) , suggesting a direct role for the a subunit of GP. More interestingly, the use of resolved a subunits of Gil, G12 and Go in reconstitution studies Vol. 255 has suggested that only a 41 kDa polypeptide (Gi1 a ?) is able to produce inhibition of adenylate cyclase . Similar debates remain as to the roles of a and /3/y subunits of pertussis toxin-sensitive G-protein (named Gk) in the control of muscarinic receptor-linked K+ channels in heart Logothetis et al., 1987 ) (see Neer, 1988 , for a detailed discussion).
Similar caveats must currently exist for other reconstitution studies which have been performed using artificial phospholipid vesicles as the milieu for interactions of 'purified' G-proteins and purified or partially purified receptors (Florio & Sternweis, 1985; Cerione et al., 1985a; Kurose et al., 1986) . However, in some instances a degree of selectivity in receptor-G-protein interactions has been noted in such reconstitution systems (Cerione et al., 1985b) . Given the complexity of the expression of the different pertussis toxin-sensitive G-proteins, in which, for example Jones & Reed (1987) noted the transcription of detectable levels of mRNAs for G., G11, G,2 and Gi3 in all tissues which they examined, it will probably require the production of protein expressed from transfection experiments (Nukada et al., 1987; Graziano et al., 1987) before reconstitution studies can be definitively performed. In this regard however, bacterially expressed protein may not be suitable if it lacks various post-translational modifications, such as the attachment of myristic acid, which presumably plays a role in the interaction of the a subunit with the membrane. Use of antisera to assess receptor-G-protein interactions Based on the knowledge that the site of pertussis toxincatalysed ADP-ribosylation, in G-proteins which are substrates for this toxin, is a conserved cysteine residue located four amino acids from the C-terminus, and also that this modification attenuates productive interactions between receptor and G-protein, it has been proposed that the C-terminal region of G-proteins is likely to represent a (the) site of receptor-G-protein contact (Masters et al., 1986; Bourne et al., 1987; McKenzie et al., 1988a,b; Hamm et al., 1987) . In the case of G, this contention has been elegantly validated by the analysis of sequence of clones of G, isolated from both wild type and the unc (uncoupled) mutant of the S49 lymphoma cell line . The unc mutant does not produce cyclic AMP upon fl-adrenergic activation (Haga et al., 1977) . Similar results have been produced by Rall & Harris (1987) . Consistent with this is the observation that the ac subunit of Gs from the unc mutation has an isoelectric point more acidic than that of wild type (Schleifer et al., 1980) . This alteration appears to be sufficient to prevent productive interaction between agonist-bound ,3 receptor and the mutant form of G,.
As similar mutants of the pertussis toxin-sensitive Gproteins have not been identified, then alternative strategies have had to be employed to address the question of which domain(s) of these G-proteins is (are) important for receptor coupling. One approach which has been successful has been to utilize either anti-peptide or monoclonal antisera directed against epitopes located either within or close to the putative receptor-recognition domain of pertussis toxin-sensitive G-proteins. Milligan and coworkers used an anti-peptide antiserum directed against the C-terminal decapeptide of the 'Gi-like' proteins to demonstrate that a 8 opioid receptor on the neuroblastoma x glioma hybrid NG 108-15 interacted exclusively with 'Gi in this cell line (McKenzie et al., 1988a,b) despite the fact that both 'Gi' and Go and potentially other uncharacterized pertussis toxin-sensitive G-proteins are expressed by these cells . These results are at variance with the conclusions of Hescheler et al. (1987) who concluded that in this cell line the opioid receptor was able to interact preferentially with Go to modulate the function of Ca2+ channels, based on reconstitution studies using 'purified' G1 and Go from brain. However, as pointed out above, these fractions were unlikely to represent homogeneous populations of a single G-protein and given the difficulty in resolving G. from G,2 in purification protocols ; P. Goldsmith, P. S. Backlund Jr., G. Milligan, C. G. Unson & A. Spiegel, unpublished work), then considerable contamination of this 'G ' preparation must be considered likely. Thus, despite the conclusive evidence that Ca21 channels can be modulated by pertussis toxin-sensitive G-proteins (Hescheler et al., 1987; Scott & Dolphin, 1987 ) the molecular identity of the Gprotein (s) has not yet been rigorously demonstrated.
Further evidence to support the selectivity of this type of antibody approach was provided in the studies of McKenzie et al. (1988a) by the observation that a growth factor receptor on this cell line, which interacts with a second pertussis toxin-sensitive G-protein, was not uncoupled from its response by antibodies affinitypurified from the anti-peptide, anti-'Gi' antiserum. This showed that the G-protein linked to the growth factor receptor must possess a C-terminal sequence distinct from that of G,. A similar approach has been utilized by Hamm and coworkers to study the interaction of rhodopsin and transducin by employing monoclonal antisera which were demonstrated to recognize an epitope near to the C-terminal region of transducin Hamm et al., 1987) . These monoclonals were able to uncouple transducin from rhodopsin but monoclonals directed against epitopes elsewhere on transducin did not.
Because the C-terminal 30 amino acids of all the 'Gilike' G-proteins are so homologous, then it must be surmised that if the extreme C-terminus of the Gproteins was to represent the only area of receptor contact then there would be little prospect that the individual forms of 'G.' could interact with different receptors (Fig. 7) . However, the region between 30 and 60 amino acids from the C-terminus of the pertussis toxin-sensitive G-proteins is one of the regions of these proteins which displays a degree of divergence at the level of amino acid sequence, and it may be that this region represents the key area in defining receptor-Gprotein contacts. Further experiments of this type may help to define the specificity or otherwise of interactions between individual receptors and different pertussis toxin substrates.
Antisera directed against sequences within the other major area of sequence divergence between these pertussis toxin-sensitive G-proteins may be useful in probing interactions of G-proteins and second messenger generation systems, as this area is likely to represent the 1988 effector-recognition domain. Other defined antisera may be useful in studies on the interactions between the individual subunits of the G-proteins. In this regard Navon & Fung (1987) have recently used monoclonal antisera directed against the N-terminus of the a. subunit of transducin to demonstrate that this region is involved in contact between the a and f/y subunits.
Although the amino acid sequences of the pertussis toxin-sensitive G-proteins may be very strongly conserved, the nucleotide sequences of the genes coding for these are less so, due to the degeneracy of the genetic code. Thus, oligonucleotides derived from cDNAs offer the potential to be very selective probes for the analysis of transcription of mRNAs coding for proteins which are very similar in amino acid sequence Murphy et al., 1987; Jones & Reed, 1987) . Although probes of this nature cannot be directly used to assess receptor-G-protein interaction, a combination of the use of oligonucleotide probes to confirm or deny the expression of individual G-proteins, and antibody probes, suggests techniques for the further progress in our understanding of the details of signal transduction processes that involve pertussis toxin-sensitive G-proteins.
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